AUS
NZ
UK
CA
USA
IND
Healt
Ebos Group Dismisses Speculation on Real Pet Food Company Acquisition
March 17, 2025 12:55 PM AEDT| By Team Kalkine MediaHighlights,Ebos,Group (,ASX:EBO,) refutes reports of pursuing Real Pet Food Company.,Company,maintains,its focus on strategic, small-to-medium acquisitions.,Official statement clarifies that the reported deal is inaccurate.,Ebos Group (ASX:EBO), a le...
EMVision prepares for crucial stroke scanner trial this year
March 17, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,EMVision progresses from development to commercialization with portable brain scanners for stroke diagnosis.,A pivotal clinical trial supporting FDA approval of the emu bedside device is set to begin.,Collaboration with Keysight Technolog...
Neurizon Therapeutics Advances Pharmacokinetic Studies to Address FDA Hold
March 17, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlight,Neurizon submits a request to the FDA for clarification on pharmacokinetic studies to lift the clinical hold on NUZ-001.,The FDA is expected to respond within 60 days, as Neurizon proactively starts the studies.,The completion of these stud...
US FDA Approvals: A Crucial Step for ASX Biotech Companies
March 17, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlight,FDA approval remains pivotal for global drug and device companies seeking market entry into the profitable US healthcare market.,ASX biotech companies experience significant share price surges following successful FDA approvals, despite the...
Race initiates its first Phase I trial location for a cardioprotective anticancer drug candidate.
March 16, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Race Oncology commences Phase I trials of RC220 in New South Wales, marking progress in its oncology treatment strategy.,The study evaluates RC220 both alone and combined with doxorubicin to assess safety and treatment compatibility.,Inter...
Race receives ethical approval for Phase I trial in patients with solid tumors.
March 14, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Ethics approval secured for a Phase I trial of RC220 bisantrene targeting solid tumors.,Patient enrollment set to begin at Southside Cancer Care Centre, with trial expansion planned.,Study to assess safety, tolerability, and pharmacokinet...
Oakridge International Insider Trust Pays Off as Stock Reaches AU$1.9 Million Market Cap
March 13, 2025 05:31 PM AEDT| By Team Kalkine MediaHighlights,Recent share surge leads to significant gains for insiders.,Executive Chairman & CEO's substantial share purchase stands out.,Strong insider ownership aligns interests with shareholders.,Insiders at Oakridge International Limited (ASX:OAK)...
We're Eager to See How Mach7 Technologies Utilizes Its Cash Reserve for Growth
March 13, 2025 05:30 PM AEDT| By Team Kalkine MediaHighlights:,Mach7 Technologies maintains a strong financial position with a substantial cash reserve and no debt.,Revenue growth has been steady, demonstrating the company’s expanding business operations.,A low cash burn relative to market capitaliza...
Early Detection of Diabetic Kidney Disease Gets a Boost with PromarkerD Launch in Australia
March 13, 2025 02:14 PM AEDT| By Team Kalkine MediaHighlights,PromarkerD,launched in Australia for early diabetic kidney disease detection,Study shows,PromarkerD,outperforms standard tests in predicting kidney function decline,Engagement with stakeholders to expand accessibility and adoption,Proteomi...
Insider Confidence in Oakridge International Strengthens as Market Value Climbs
March 13, 2025 01:39 PM AEDT| By Team Kalkine MediaHighlights:,Oakridge International (,ASX:OAK,) sees an 11% stock surge, boosting market cap by AU$189k.,Insider purchases from the past year now reflect a 33% gain.,Executive,Chairman,& CEO’s AU$500k investment aligns leadership with shareholder inte...
TrivarX alerts to US Veterans Affairs mental health trial—then suspends trading for fundraising effort
March 13, 2025 12:30 PM AEDT| By Team Kalkine MediaHighlights:,TrivarX collaborates with the US Department of Veterans Affairs for a clinical trial focused on mental health diagnostics.,The trial will assess an advanced algorithm that analyzes heart rate data during sleep to identify depressive episo...
Livium Clears Lind Facility Repayments Following $4.5M Capital Injection
March 13, 2025 12:05 PM AEDT| By Team Kalkine MediaHighlights,Livium,(,ASX:LIV,) completes full repayment of Lind Facility.,No new shares issued as part of the settlement.,Institutional and sophisticated investors contribute A$4.5 million.,Livium Ltd (ASX:LIV) has successfully finalized all necessary...
Revolutionizing Diabetes Care: (ASX:PIQ) Unveils Promarker®D Test to Predict Kidney Disease Risk
March 13, 2025 11:58 AM AEDT| By Team Kalkine MediaHighlights,Advanced Diagnostic Tool:,Promarker®D,predicts chronic kidney disease up to four years in advance.,Nationwide Availability:,Initial rollout in Western Australia and the Northern Territory, with plans to expand across Australia.,Global Expa...
Avecho Biotechnology Reports Strong Revenue Growth Amid Share Price Decline
March 13, 2025 11:31 AM AEDT| By Team Kalkine MediaHighlights:,Revenue experienced a substantial increase compared to the previous fiscal period.,A decline in net loss reflects an improvement in financial performance.,Share value moved lower over the past week.,Avecho Biotechnology (ASX:AVE) , operat...
Health Check: Celebrate the Diligent Bodily 'Spuds' on World Kidney Day
March 13, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Proteomics International Laboratories launched Promarker D in Australia for diabetic kidney disease detection.,Dimerix continues progress in a late-stage trial for a focal glomerulosclerosis treatment.,Trivarx collaborates with the US Vet...
Emerging Trends in ASX Pharmaceuticals: Commercialization and Telehealth Initiatives
March 13, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlight,ASX pharmaceutical companies focus on retaining assets longer for direct commercialization.,LTR Pharma is leveraging telehealth for its novel nasal spray market expansion.,Botanix Pharmaceuticals pursues independent US commercialization wit...
CurveBeam AI (ASX:CVB) is Utilizing a Moderate Level of Debt
March 12, 2025 03:30 PM AEDT| By Team Kalkine MediaHighlights:,CurveBeam AI operates within the medical technology sector, focusing on advanced imaging solutions.,The company holds a notable level of debt, with financial obligations exceeding available liquid assets.,Revenue decline and operational l...
Telix Pharmaceuticals (ASX:TLX) Strengthens Cancer Pipeline with FAP-Targeting Acquisition
March 12, 2025 02:38 PM AEDT| By Team Kalkine MediaHighlights,Strategic Expansion:,Telix,Pharmaceuticals (,ASX:TLX,) enhances its nuclear medicine pipeline.,New,Theranostic,Focus:,Addition of TLX400 advances bladder cancer and pan-cancer applications.,Global Potential:,Clinically validated radiopharm...
Healthcare Stocks to Watch: A Look at (ASX:SHL) and (ASX:PME) in 2025
March 12, 2025 01:12 PM AEDT| By Team Kalkine MediaHighlights,Sonic Healthcare,has seen a decline of 6.2% since the start of 2025, while (,ASX:PME,),remains,25.7% below its 52-week high.,Sonic Healthcare is a global leader in pathology and diagnostic services, serving multiple regions.,Pro Medicus sp...
Beamtree Holdings Limited Faces a Challenging Period
March 11, 2025 07:35 PM AEDT| By Team Kalkine MediaHighlights,Beamtree Holdings Limited (ASX: BMT) shares slump by 28% over the past month.,Company's Price-to-Sales ratio is low compared to industry standards.,Revenue growth forecasts trail the industry expectations significantly.,In recent weeks, Be...
Advertise your brand on Kalkine Media